Yang WP - Search Results

1

Sorafenib-based therapy in HER2-negative advanced breast cancer: Results from a retrospective pooled analysis of randomized controlled trials.

Tan QX, Qin QH, Lian B, Yang WP, Wei CY. Tan QX, et al. Among authors: yang wp. Exp Ther Med. 2014 May;7(5):1420-1426. doi: 10.3892/etm.2014.1603. Epub 2014 Mar 5. Exp Ther Med. 2014. PMID: 24940450 Free PMC article.

2

Prognostic value of hormone receptor status conversion following neoadjuvant chemotherapy in a series of operable breast cancer patients.

Tan QX, Qin QH, Yang WP, Lian B, Wei CY. Tan QX, et al. Among authors: yang wp. Int J Clin Exp Pathol. 2014 Jun 15;7(7):4086-94. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25120787 Free PMC article.

3

Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.

Tan QX, Qin QH, Yang WP, Mo QG, Wei CY. Tan QX, et al. Among authors: yang wp. Int J Clin Exp Pathol. 2014 Sep 15;7(10):6862-70. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25400769 Free PMC article.

4

Radiobiological effect induced by different activities of (125)I seed brachytherapy in a hepatocellular carcinoma model.

Qin QH, Huang BS, Tan QX, Yang WP, Lian B, Wei CY. Qin QH, et al. Among authors: yang wp. Int J Clin Exp Med. 2014 Dec 15;7(12):5260-7. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25664029 Free PMC article.

5

Harmonic Scalpel versus Electrocautery Dissection in Modified Radical Mastectomy for Breast Cancer: A Meta-Analysis.

Huang J, Yu Y, Wei C, Qin Q, Mo Q, Yang W. Huang J, et al. PLoS One. 2015 Nov 6;10(11):e0142271. doi: 10.1371/journal.pone.0142271. eCollection 2015. PLoS One. 2015. PMID: 26544716 Free PMC article.

6

Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.

Wei CY, Tan QX, Zhu X, Qin QH, Zhu FB, Mo QG, Yang WP. Wei CY, et al. Among authors: yang wp. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14619-29. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823785 Free PMC article.

7

Trace Elements and Chemotherapy Sensitivity.

Liu Z, Yang W, Long G, Wei C. Liu Z, et al. Biol Trace Elem Res. 2016 Oct;173(2):283-90. doi: 10.1007/s12011-016-0667-6. Epub 2016 Mar 9. Biol Trace Elem Res. 2016. PMID: 26961293 Clinical Trial.

8

p53 inhibits the expression of p125 and the methylation of POLD1 gene promoter by downregulating the Sp1-induced DNMT1 activities in breast cancer.

Zhang L, Yang W, Zhu X, Wei C. Zhang L, et al. Onco Targets Ther. 2016 Mar 10;9:1351-60. doi: 10.2147/OTT.S98713. eCollection 2016. Onco Targets Ther. 2016. PMID: 27022290 Free PMC article.

9

Combination of 125I brachytherapy and chemotherapy for unresectable recurrent breast cancer: A retrospective control study.

Tan Q, Qin Q, Yang W, Lian B, Mo Q, Wei C. Tan Q, et al. Medicine (Baltimore). 2016 Nov;95(44):e5302. doi: 10.1097/MD.0000000000005302. Medicine (Baltimore). 2016. PMID: 27858906 Free PMC article.

10

Elevated expression of POLD1 is associated with poor prognosis in breast cancer.

Qin Q, Tan Q, Li J, Yang W, Lian B, Mo Q, Wei C. Qin Q, et al. Oncol Lett. 2018 Nov;16(5):5591-5598. doi: 10.3892/ol.2018.9392. Epub 2018 Sep 4. Oncol Lett. 2018. PMID: 30344713 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters